Baseclick

at baseclick we believe that bioconjugation is not just a method to connect (bio)molecules, but a tool to develop valuable applications. simple methods for efficient and robust nucleic acid labeling are at the core of the baseclick technology. our mission is to develop and provide the best nucleic acid labeling applications and reagents for the life science market. history in 2008 basf venture capital and prof. thomas carell from the lmu munich started to turn this mission into reality and founded baseclick gmbh, with its site close to munich. back then, it was very hard, using standard labeling techniques such as dye-building blocks, nhs-chemistry or other techniques to efficiently modify nucleic acids with multiple modifications. this was due to a lack of efficiency and simplicity in labeling technology. so, a new strategy was needed: click chemistry! since then scientists at baseclick and elsewhere are improving the technology and widening its scope by creating inventive application